Norges Bank T Scan Therapeutics, Inc. Transaction History

Norges Bank

  • $716 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2023
BUY
$2.8 - $5.4 $168,000 - $324,000
60,000 New
60,000 $168,000
Q1 2022

May 09, 2022
SELL
$2.8 - $5.4 $168,000 - $324,000
-60,000 Closed
0 $0
Q4 2021

Mar 09, 2022
BUY
$4.5 - $9.05 $270,000 - $543,000
60,000 New
60,000 $270,000
Q3 2021

Nov 14, 2022
BUY
$6.17 - $13.48 $370,200 - $808,800
60,000 New
60,000 $500,000

Others Institutions Holding TCRX

# of Institutions
89
Shares Held
41.8M
Call Options Held
0
Put Options Held
0
View Full List

About TScan Therapeutics, Inc.

TCRX Quotes by TradingView
  • Ticker TCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,929,800
  • Market Cap $57.9M
  • Description
  • TScan Therapeutics, Inc., a preclinical-stage biopharmaceutical company, develops T cell receptor-engineered T cell therapies for the treatment of patients with cancer. It is developing TSC-100 and TSC-101 for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell ...
More about TCRX
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email